Drew Hope, PhD, BSc (Hons), MRSB, GMP compliance consultant and UK qualified person at eXmoor Pharma, looks at what manufacturers should expect from a contract QP.
Bracco Imaging, a pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, has announced the expansion of its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit.
EpilepsyGTx and ClearPoint Neuro have announced a partnership to support the targeted delivery of EpilepsyGTx’s lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).
CoolCell cell freezing containers from Azenta Life Sciences deliver reproducible cryopreservation while eliminating the need for alcohol-based freezing methods.
Autolomous and Cellular Origins has announced end-to-end integration of their respective platforms, bringing full automation and digitisation to the entire cell therapy manufacturing process.
Circio Holding and Tcelltech has announced a research collaboration to combine Circio's circVec circular RNA expression technology with Tcelltech's non-integrating nanoSMAR vector platform for the development of next gen engineered T-cell therapies.
NunaBio, a next-gen DNA manufacturing company, has secured £6.5 million in funding to scale-up its DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research.
